Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice.

AIM To study the inhibitory effect of oxymatrine on serum hepatitis B virus (HBV) DNA in HBV transgenic mice. METHODS HBV transgenic mice model was established by microinjection, and identified by HBV DNA integration and replication. Transgenic mice with replicating HBV were divided into 3 groups, and injected with normal saline (group A, n=9), 50 mg/kg (group B, n=8) and 100 mg/kg (group C, n=9) oxymatrine intraperitoneally once a day for 30 d, respectively. Quantitation of serum HBV DNA in HBV transgenic mice was performed by competitive polymerase chain reaction (PCR) in combination with DNA hybridization quantitative detection technique before and after treatment. RESULTS Compared with pre-treatment, the serum HBV DNA in group A (F=1.04, P=0.9612) and group B (F=1.13, P=0.8739) had no changes after treatment. However, in group C serum HBV DNA was significantly decreased (F=13.97, P=0.0012). The serum HBV DNA after treatment was lower in group C than in groups B and A (F=8.65, P=0.0068; F=12.35, P=0.0018; respectively). The serum HBV DNA after treatment was lower in group B than in group A, but there was no statistical significance (F=1.43, P=0.652). CONCLUSION Oxymatrine has inhibitory effects on serum HBV DNA in HBV transgenic mice.

[1]  Vijay Kumar,et al.  Transgenic mouse models of hepatitis B virus‐associated hepatocellular carcinoma , 2003, Reviews in medical virology.

[2]  Jianpin Liu,et al.  Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized Trials , 2003, American Journal of Gastroenterology.

[3]  Kan Jiang,et al.  Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti‐hepatitis B virus mechanism of oxymatrine , 2002, Journal of gastroenterology and hepatology.

[4]  Z. Hong,et al.  Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy. , 2002, Gastroenterology.

[5]  Shu-hua Guo,et al.  [A clinical research on oxymatrine for the treatment of chronic hepatitis B]. , 2002, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[6]  R. Sidwell,et al.  Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. , 2002, Antiviral research.

[7]  M. Lutz,et al.  Assessment of the COBAS Amplicor HBV Monitor Test for Quantitation of Serum Hepatitis B Virus DNA Levels , 2002, Journal of Clinical Microbiology.

[8]  Lungen Lu,et al.  [Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis]. , 2002, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[9]  D. Paraskevis,et al.  Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. , 2002, Journal of virological methods.

[10]  K. Schlemmer,et al.  Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. , 2002, Antiviral research.

[11]  Y. Chen,et al.  [Relationship between serum load of HBV-DNA and therapeutic effect of oxymatrine in patients with chronic hepatitis B]. , 2002, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[12]  Xiong Cai,et al.  Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. , 2002, Chinese medical journal.

[13]  F. Chisari,et al.  Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice , 2002, Journal of Virology.

[14]  Wenjie Tan,et al.  Enhancement of Hepatitis B Virus Replication by Its X Protein in Transgenic Mice , 2002, Journal of Virology.

[15]  R. Perrillo.  How will we use the new antiviral agents for hepatitis B? , 2002, Current gastroenterology reports.

[16]  G. Usluer,et al.  Comparison of Different Treatment Combinations for Chronic Hepatitis B Infection , 2002, Journal of chemotherapy.

[17]  J. Larkin,et al.  Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice , 2001, Hepatology.

[18]  M. Poljak,et al.  Second-generation Hybrid capture test and Amplicor monitor test generate highly correlated hepatitis B virus DNA levels. , 2001, Journal of virological methods.

[19]  M. Zeng,et al.  [The inhibitory effect of oxymatrine on hepatitis C virus in vitro]. , 2001, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[20]  D. Mutimer.  Hepatitis B virus infection: resistance to antiviral agents. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  G. Lau.  Hepatitis B infection in China. , 2001, Clinics in liver disease.

[22]  S. Zhang,et al.  Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes. , 2001, World journal of gastroenterology.

[23]  G. Wang,et al.  Inhibition of hepatitis B virus by oxymatrine in vivo. , 2001, World journal of gastroenterology.

[24]  M. Poljak,et al.  Comparative Evaluation of Semiautomated COBAS AMPLICOR Hepatitis B Virus (HBV) MONITOR Test and Manual Microwell Plate-Based AMPLICOR HBV MONITOR Test , 2001, Journal of Clinical Microbiology.

[25]  J. Colacino,et al.  Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection. , 2001, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[26]  M. Yamazaki.  [The pharmacological studies on matrine and oxymatrine]. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[27]  J. Sung,et al.  Comparison of Three Different Sensitive Assays for Hepatitis B Virus DNA in Monitoring of Responses to Antiviral Therapy , 2000, Journal of Clinical Microbiology.

[28]  William Lee,et al.  Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium , 2000, Annals of Internal Medicine.

[29]  Bao-en Wang,et al.  Treatment of chronic liver diseases with traditional Chinese medicine , 2000, Journal of gastroenterology and hepatology.

[30]  E. Wiedenmann,et al.  Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). , 2000, Journal of virological methods.

[31]  S. Locarnini,et al.  Antiviral chemotherapy for the treatment of hepatitis B virus infections. , 2000, Gastroenterology.

[32]  Anders Hedrum,et al.  Automated Quantitative Analysis of Hepatitis B Virus DNA by Using the Cobas Amplicor HBV Monitor Test , 1999, Journal of Clinical Microbiology.

[33]  L. Siracusa,et al.  Hepatitis B virus transgenic mouse model of chronic liver disease , 1999, Nature Medicine.

[34]  Yong Cheng,et al.  Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene. , 1998, World journal of gastroenterology.

[35]  M. Onji,et al.  Hepatitis B virus (HBV)‐transgenic mice as an investigative tool to study immunopathology during HBV infection , 1998, International journal of experimental pathology.

[36]  D. Qiu,et al.  Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C , 1998, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[37]  R. Sidwell,et al.  Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. , 1998, Antiviral therapy.

[38]  K. Yamamura,et al.  Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. , 1997, Biochemical and biophysical research communications.

[39]  K. Choo,et al.  Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse. , 1991, Virology.

[40]  J. Miyazaki,et al.  Expression and replication of hepatitis B virus genome in transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Palmiter,et al.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. , 1985, Science.